» Articles » PMID: 1684372

In Vivo Induction of Cytotoxic T Cell Response by a Free Synthetic Peptide Requires CD4+ T Cell Help

Overview
Journal J Immunol
Date 1991 Dec 15
PMID 1684372
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Most attempts to induce CTL responses by in vivo priming with free synthetic peptides have been unsuccessful so far. However, two separate studies have recently succeeded in inducing antiviral CTL responses by immunizing mice with unmodified free synthetic peptides derived from nucleoproteins from either lymphocytic choriomeningitis virus or Sendai virus. In the present study, we have analyzed the cellular mechanisms by which the lymphocytic choriomeningitis virus synthetic peptide induced CTL responses. We demonstrated that this peptide, which was previously shown to be recognized by CD8+ T cells, also contains a helper CD4+ T cell epitope. It stimulates in vivo both CD4+ T cell-mediated CTL response. The in vivo elimination of CD4+ T cells by treatment with a mAb was shown to strongly reduce the antipeptide CTL response. This study therefore demonstrates that to be able to induce CTL responses, a peptide has to stimulate both CD4+ and CD8+ T cell subset.

Citing Articles

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.

Dolina J, Lee J, Brightman S, McArdle S, Hall S, Thota R J Clin Invest. 2023; 133(17).

PMID: 37655661 PMC: 10471175. DOI: 10.1172/JCI164258.


Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4 and CD8 T cells for immunotherapy of cancer.

Melssen M, Fisher C, Slingluff C, Melief C J Immunother Cancer. 2023; 10(9).

PMID: 36939214 PMC: 9472143. DOI: 10.1136/jitc-2022-004709.


A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope.

Swartz A, Congdon K, Nair S, Li Q, Herndon 2nd J, Suryadevara C NPJ Vaccines. 2021; 6(1):12.

PMID: 33462231 PMC: 7814002. DOI: 10.1038/s41541-020-00273-5.


HCV p7 as a novel vaccine-target inducing multifunctional CD4 and CD8 T-cells targeting liver cells expressing the viral antigen.

Filskov J, Andersen P, Agger E, Bukh J Sci Rep. 2019; 9(1):14085.

PMID: 31575882 PMC: 6773770. DOI: 10.1038/s41598-019-50365-z.


Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8 T and T Cell Responses against Herpesvirus Infection and Disease.

Lopes P, Todorov G, Pham T, Nesburn A, Bahraoui E, BenMohamed L J Virol. 2018; 92(8).

PMID: 29437976 PMC: 5874417. DOI: 10.1128/JVI.02156-17.